[Clinical aspects of a synchronous cancerous lesion of the corpus uteri and the ovaries].

[Cytodiagnosis of endometrial cancer]. Vopr Onkol (1979) 0.75

[Ways of reducing the toxicity of chemotherapy of cancer of the ovaries]. Sov Med (1986) 0.75

[Rehabilitation potentials for young patients following the treatment of malignant ovarian tumors]. Akush Ginekol (Mosk) (1984) 0.75

[The role of hormone therapy in the treatment of cancer of the endometrium]. Vopr Onkol (1983) 0.75

[Principles of specialized oncogynecologic services]. Sov Zdravookhr (1989) 0.75

[The possibility of detecting ascites on survey roentgenograms of the abdominal cavity]. Vestn Rentgenol Radiol (1973) 0.75

[Combined and surgical treatment of cervical cancer]. Vopr Onkol (1980) 0.75

[Research trends in oncological gynecology]. Akush Ginekol (Mosk) (1980) 0.75

[Clinical characteristics of malignant ovarian tumors in childhood and youth]. Akush Ginekol (Mosk) (1979) 0.75

[Diagnosis of ovarian neoplasms at various stages of examination]. Sov Med (1978) 0.75

[Diagnosis of early forms of cancer of the endometrium: problems and perspectives]. Sov Med (1987) 0.75

[Humoral immunity to herpes simplex virus type 2 in cervical cancer]. Vopr Virusol (1982) 0.75

[Personnel training for fulfilling the requirements of the Cervical Cancer Program in the Russian Federation]. Akush Ginekol (Mosk) (1984) 0.75

[The role of herpetic infection in epithelial dysplasias of the cervix uteri and a trial of their treatment with antiherpetic preparations]. Vopr Virusol (1991) 0.75

[Changes in the upper urinary tract during combined treatment of cancer of the uterine cervix]. Vopr Onkol (1970) 0.75

[Additional methods of examination in the diagnosis of recurrence of cervical cancer]. Sov Med (1976) 0.75

[Hemosorption as a method of 5-fluorouracil elimination]. Vopr Onkol (1983) 0.75

[Current aspects of the early detection of endometrial cancer]. Akush Ginekol (Mosk) (1979) 0.75

[Genital herpes and cervical cancer]. Vestn Dermatol Venerol (1981) 0.75

[Functional status of lymphocytes in malignant tumors of the ovaries]. Sov Med (1986) 0.75

[Toxic reactions during treatment of the ovarian cancer with ThioTEPA]. Akush Ginekol (Mosk) (1974) 0.75

[Radioisotope renography with I-131 hippuran in evaluation of the condition of the urinary system in cervical cancer]. Vopr Onkol (1970) 0.75

[Work capacity of women cured of cervical cancer and the problems of their work rehabilitation]. Sov Zdravookhr (1982) 0.75

[Clinico-morphologic parallels in synchronous cancer of the endometrium and ovaries]. Vopr Onkol (1989) 0.75

[Treatment of patients with 1B-stage cervical cancer]. Vopr Onkol (1989) 0.75

[Radioisotope renography in patients with cancer of the cervix]. Med Radiol (Mosk) (1970) 0.75

[Clinico-morphological changes during treatment of endometrial cancer with progestins]. Vopr Onkol (1980) 0.75

[Organ-preserving treatment in oncogynecology]. Vopr Onkol (1987) 0.75

[Emergency surgical interventions in malignant tumors of the ovaries]. Khirurgiia (Mosk) (1987) 0.75

[Results of working on the problem of cervical cancer within the framework of a goal-directed program]. Sov Med (1985) 0.75

[Errors in the treatment of patients with initial forms of cancer of the cervix uteri]. Akush Ginekol (Mosk) (1988) 0.75

[Malignant tumors of the ovaries in young people]. Sov Med (1984) 0.75

[Errors in the diagnosis of early forms of cancer of the cervix uteri]. Akush Ginekol (Mosk) (1989) 0.75

[Individual sensitivity of ovarian ascitic cancer to thiophosphamide]. Vopr Onkol (1974) 0.75

[Determination of the individual sensitivity of ovarian ascitic cancer cells in vitro by cytological criteria]. Vopr Onkol (1979) 0.75